These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33934075)

  • 1. Changes in Treatments and Outcomes After Implementation of a National Universal Access Program for Juvenile Idiopathic Arthritis.
    Concha S; Morales PS; Talesnik E; Borzutzky A
    J Rheumatol; 2021 Nov; 48(11):1725-1731. PubMed ID: 33934075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of pediatric rheumatologists and transitional care for juvenile idiopathic arthritis-associated uveitis: a retrospective series of 9 cases.
    Yamazaki S; Shimbo A; Akutsu Y; Takase H; Morio T; Mori M
    Pediatr Rheumatol Online J; 2020 Mar; 18(1):26. PubMed ID: 32293465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subtype frequencies, demographic features, and remission rates in juvenile idiopathic arthritis - 265 cases from a Turkish center.
    Çakan M; Aktay-Ayaz N; Keskindemirci G; Ekinci DY; Karadağ ŞG
    Turk J Pediatr; 2017; 59(5):548-554. PubMed ID: 29745116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uveitis in Juvenile Idiopathic Arthritis: 18-Year Outcome in the Population-based Nordic Cohort Study.
    Rypdal V; Glerup M; Songstad NT; Bertelsen G; Christoffersen T; Arnstad ED; Aalto K; Berntson L; Fasth A; Herlin T; Ekelund M; Peltoniemi S; Toftedal P; Nielsen S; Leinonen S; Bangsgaard R; Nielsen R; Rygg M; Nordal E;
    Ophthalmology; 2021 Apr; 128(4):598-608. PubMed ID: 32866542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors and biomarkers for the 2-year outcome of uveitis in juvenile idiopathic arthritis: data from the Inception Cohort of Newly diagnosed patients with Juvenile Idiopathic Arthritis (ICON-JIA) study.
    Heiligenhaus A; Klotsche J; Tappeiner C; Sengler C; Niewerth M; Liedmann I; Hoeft S; Walscheid K; Lavric M; Foell D; Minden K
    Rheumatology (Oxford); 2019 Jun; 58(6):975-986. PubMed ID: 30590748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors and Biomarkers for the Occurrence of Uveitis in Juvenile Idiopathic Arthritis: Data From the Inception Cohort of Newly Diagnosed Patients With Juvenile Idiopathic Arthritis Study.
    Tappeiner C; Klotsche J; Sengler C; Niewerth M; Liedmann I; Walscheid K; Lavric M; Foell D; Minden K; Heiligenhaus A
    Arthritis Rheumatol; 2018 Oct; 70(10):1685-1694. PubMed ID: 29732713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT.
    Ramanan AV; Dick AD; Jones AP; Hughes DA; McKay A; Rosala-Hallas A; Williamson PR; Hardwick B; Hickey H; Rainford N; Hickey G; Kolamunnage-Dona R; Culeddu G; Plumpton C; Wood E; Compeyrot-Lacassagne S; Woo P; Edelsten C; Beresford MW
    Health Technol Assess; 2019 Apr; 23(15):1-140. PubMed ID: 31033434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The frequency and outcome of uveitis in patients with newly diagnosed juvenile idiopathic arthritis in two 4-year cohorts from 1990-1993 and 2000-2003.
    Kotaniemi K; Sihto-Kauppi K; Salomaa P; Säilä H; Ristolainen L; Kauppi M
    Clin Exp Rheumatol; 2014; 32(1):143-7. PubMed ID: 24351424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of adalimumab as the first and second biologic agent in juvenile idiopathic arthritis: the German Biologics JIA Registry.
    Schmeling H; Minden K; Foeldvari I; Ganser G; Hospach T; Horneff G
    Arthritis Rheumatol; 2014 Sep; 66(9):2580-9. PubMed ID: 24942886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of Uveitis in Juvenile Idiopathic Arthritis and Spondyloarthritis Patients - A 5-Year Follow-Up Study.
    Oliveira Pinheiro F; Leuzinger-Dias M; Fernandes BM; Fonseca D; Vilaça J; Figueira L; Brito I
    ARP Rheumatol; 2023; 2(1):17-21. PubMed ID: 36842134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Juvenile idiopathic arthritis-associated uveitis.
    Sen ES; Ramanan AV
    Clin Immunol; 2020 Feb; 211():108322. PubMed ID: 31830532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Juvenile idiopathic arthritis in Southeast Asia: the Singapore experience over two decades.
    Tanya M; Teh KL; Das L; Hoh SF; Gao X; Arkachaisri T
    Clin Rheumatol; 2020 Nov; 39(11):3455-3464. PubMed ID: 32418038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear cataract as an early predictive factor for recalcitrant juvenile idiopathic arthritis-associated uveitis.
    Suelves AM; Lamba N; Meese HK; Foster CS; González-Martín JM; Díaz-Llopis M; Christen WG
    J AAPOS; 2016 Jun; 20(3):232-238.e1. PubMed ID: 27164426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic advances in juvenile idiopathic arthritis - associated uveitis.
    Gueudry J; Touhami S; Quartier P; Bodaghi B
    Curr Opin Ophthalmol; 2019 May; 30(3):179-186. PubMed ID: 30844943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register.
    Otten MH; Anink J; Prince FH; Twilt M; Vastert SJ; ten Cate R; Hoppenreijs EP; Armbrust W; Gorter SL; van Pelt PA; Kamphuis SS; Dolman KM; Swart JF; van den Berg JM; Koopman-Keemink Y; van Rossum MA; Wulffraat NM; van Suijlekom-Smit LW
    Ann Rheum Dis; 2015 Jul; 74(7):1379-86. PubMed ID: 24641940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Antiinflammatory Treatment on the Onset of Uveitis in Juvenile Idiopathic Arthritis: Longitudinal Analysis From a Nationwide Pediatric Rheumatology Database.
    Tappeiner C; Schenck S; Niewerth M; Heiligenhaus A; Minden K; Klotsche J
    Arthritis Care Res (Hoboken); 2016 Jan; 68(1):46-54. PubMed ID: 26212111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features in 305 patients with juvenile idiopathic arthritis: A single center Turkish Study.
    Ozdel S; Baglan E; Cakıcı EK; Yazılıtas F; Yücel H; Senel S; Bulbul M
    Pediatr Int; 2021 Jun; 63(6):636-642. PubMed ID: 32969552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence and adverse events of biological treatment in adult patients with juvenile idiopathic arthritis: results from BIOBADASER.
    Bethencourt Baute JJ; Sanchez-Piedra C; Ruiz-Montesinos D; Medrano San Ildefonso M; Rodriguez-Lozano C; Perez-Pampin E; Ortiz A; Manrique S; Roselló R; Hernandez V; Campos C; Sellas A; Sifuentes-Giraldo WA; García-González J; Sanchez-Alonso F; Díaz-González F; Gómez-Reino JJ; Bustabad Reyes S;
    Arthritis Res Ther; 2018 Oct; 20(1):227. PubMed ID: 30305158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Juvenile idiopathic arthritis-associated uveitis: a nationwide population-based study in Taiwan.
    Yu HH; Chen PC; Wang LC; Lee JH; Lin YT; Yang YH; Lin CP; Chiang BL
    PLoS One; 2013; 8(8):e70625. PubMed ID: 23940609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment Withdrawal Following Remission in Juvenile Idiopathic Arthritis: A Systematic Review of the Literature.
    Halyabar O; Mehta J; Ringold S; Rumsey DG; Horton DB
    Paediatr Drugs; 2019 Dec; 21(6):469-492. PubMed ID: 31673960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.